14 February 2025
14 February 2025
Allurion’s CEO confirmed to Medical Device Network that the company has changed advertising, patient follow-up, and physician training.
The study follows a strategic outsourcing collaboration announced in September 2022.
The provision will enable whole genome sequencing for neonatal and paediatric patients in intensive care units within 48 hours.
Medical Device Network sits down with David Leslie of the Alan Turing Institute to understand what, if any, rules AI should live by to make patients feel at ease.
Leveraging the Iona Nx NIPT Workflow, the service claims to deliver fast, accurate, and safe prenatal testing outcomes.
Prenuvo teased it has received FDA clearance for its new AI-powered body composition report software.
Tempus will help further the commercialisation of Artera’s ArteraAI prostate cancer test.
The Quest Diagnostics connectivity system allows US providers to order the test directly.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
